Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Currie

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Neurogastroenterology and Motility|February 7, 2013
An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trialsJ E Macdougall, J M Johnston, B J Lavins, et al.
Cancer Research|October 4, 2000
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMPK Shailubhai, H H Yu, K Karunanandaa, et al.
Journal of Medicinal Chemistry|May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)D W Hansen, K B Peterson, M Trivedi, et al.
Journal of Medicinal Chemistry|January 23, 1998
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoformsR K Webber, S Metz, W M Moore, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 10, 2000
Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsisD J Fretland, D L Widomski, C P Anglin, et al.
Journal of Medicinal Chemistry|September 11, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthaseT J Hagen, A A Bergmanis, S W Kramer, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Neurogastroenterology and Motility|February 7, 2013
An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trialsJ E Macdougall, J M Johnston, B J Lavins, et al.
Cancer Research|October 4, 2000
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMPK Shailubhai, H H Yu, K Karunanandaa, et al.
Journal of Medicinal Chemistry|May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)D W Hansen, K B Peterson, M Trivedi, et al.
Journal of Medicinal Chemistry|January 23, 1998
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoformsR K Webber, S Metz, W M Moore, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 10, 2000
Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsisD J Fretland, D L Widomski, C P Anglin, et al.
Journal of Medicinal Chemistry|September 11, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthaseT J Hagen, A A Bergmanis, S W Kramer, et al.
Pageof 11